Elanco Wins Full USDA Approval for Trutect Canine Parvovirus Treatment
I'm PortAI, I can summarize articles.
Elanco Animal Health Inc. has received full USDA approval for Trutect™, a groundbreaking treatment for canine parvovirus. This follows a conditional approval in September 2023 and marks a significant milestone for the company. Trutect is now approved for passive immunity, allowing its use as a preventative measure for exposed puppies. The original content was published by Elanco on December 15, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments